We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

AnaSpec and Cyclex Co. Ltd. have announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent.

"We are pleased to partner with Cyclex in expanding our array of next generation assay kits," noted Dr. Anita Hong, AnaSpec's president.

"The new SensoLyte™ HDAC assay kits will provide our customers with new long wavelength options for the detection of histone deacetylase activity. AnaSpec also plans to develop other long wavelength HDAC related kits including SIRT assay kits."